Physician profile
Thomas M Matelic
NPI 1700873874
$9,771.11
in general payments reported to CMS, 2019-2025
10 companies · $1,106 in 2025
The $1,106 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,930 · 2020: $881 · 2021: $150 · 2022: $1,588 · 2023: $2,103 · 2024: $13.86 · 2025: $1,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,831 · Food and Beverage: $1,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,830.71 |
| Food and Beverage | $1,392.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $4,085.63 | 2019-2023 | |
| Arthrex, INC. | $2,842.00 | 2019-2025 | |
| Lima USA, INC. | $858.28 | 2020 | |
| Zimmer Biomet Holdings, INC. | $592.29 | 2019-2025 | Rosa, Tapestry |
| Smith+Nephew, INC. | $491.04 | 2019-2025 | Evos, Q-Fix, Real Intelligence |
| Zak Ortho | $365.35 | 2025 | |
| Stryker Corporation | $215.33 | 2023-2025 | Mako, Infinity, Ortholoc 3di |
| Depuy Synthes Sales INC. | $172.85 | 2021-2023 | Attune |
| Vericel Corporation | $124.99 | 2019 | |
| Medical Device Business Services, INC. | $23.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Matelic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.